CYP20A1
Cytochrome P450 20A1
Also known as: CP20A_HUMAN, CYP-M
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UW02
- Gene
- CYP20A1
- Ensembl
- ENSG00000119004
- Chromosome
- 2
- Canonical length
- 462 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments
OverviewNCBI Gene
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein lacks one amino acid of the conserved heme binding site. It also lacks the conserved I-helix motif AGX(D,E)T, suggesting that its substrate may carry its own oxygen. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
462 residues, UniProt reviewed canonical sequence.
>Q6UW02|CYP20A1
1 MLDFAIFAVT FLLALVGAVL YLYPASRQAA GIPGITPTEE KDGNLPDIVN SGSLHEFLVN
61 LHERYGPVVS FWFGRRLVVS LGTVDVLKQH INPNKTSDPF ETMLKSLLRY QSGGGSVSEN
121 HMRKKLYENG VTDSLKSNFA LLLKLSEELL DKWLSYPETQ HVPLSQHMLG FAMKSVTQMV
181 MGSTFEDDQE VIRFQKNHGT VWSEIGKGFL DGSLDKNMTR KKQYEDALMQ LESVLRNIIK
241 ERKGRNFSQH IFIDSLVQGN LNDQQILEDS MIFSLASCII TAKLCTWAIC FLTTSEEVQK
301 KLYEEINQVF GNGPVTPEKI EQLRYCQHVL CETVRTAKLT PVSAQLQDIE GKIDRFIIPR
361 ETLVLYALGV VLQDPNTWPS PHKFDPDRFD DELVMKTFSS LGFSGTQECP ELRFAYMVTT
421 VLLSVLVKRL HLLSVEGQVI ETKYELVTSS REEAWITVSK RYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP20A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 4.6 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 4.6 nTPM
- kidney: 4.2 nTPM
- skin: 3.5 nTPM
- ovary: 3.4 nTPM
- lymph node: 3.3 nTPM
- adrenal gland: 3 nTPM
Single-cell type
- early primary spermatocytes: 207 nCPM
- leydig cells: 189 nCPM
- sertoli cells: 151 nCPM
- granulosa cells: 148 nCPM
- plasma cells: 144 nCPM
- early spermatids: 138 nCPM
Immune cell
- naive B-cell: 9.3 nTPM
- T-reg: 7.7 nTPM
- memory CD4 T-cell: 7.4 nTPM
- plasmacytoid DC: 6.9 nTPM
- MAIT T-cell: 6.2 nTPM
- non-classical monocyte: 6 nTPM
Brain region
- white matter: 17 nTPM
- medulla oblongata: 16 nTPM
- choroid plexus: 15 nTPM
- basal ganglia: 15 nTPM
- thalamus: 14 nTPM
- cerebral cortex: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.37
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.37
- DepMap mean gene effect
- 0.17
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
- heme binding
- iron ion binding
- monooxygenase activity
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cytochrome P450
- Cytochrome P450, E-class, group I
- Cytochrome P450 superfamily
- Cytochrome P450
- Cytochrome P450 20A1-like
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP20A1 as an antibody target. Whether an autoantibody or antibody against CYP20A1 could matter depends on whether native CYP20A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP20A1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP20A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...